Stock-Based Compensation

3 Months Ended

Mar. 31, 2022

Share-based Payment Arrangement [Abstract]

2021 SI Plan

In July 2021, the Company adopted the 2021 Stock Incentive Plan (“2021 SI Plan”). The 2021 SI Plan allows the Board of Directors to grant up to 49,573,570 incentive and nonqualified stock options, restricted shares, unrestricted shares, restricted share units, and other stock-based awards for the Company’s Class A Common Stock to employees, directors, and non-employees. The number of shares of Class A Common Stock available under the 2021 SI Plan will increase annually on the first day of each calendar year, beginning with the calendar year ending December 31, 2022, and continuing until (and including) the calendar year ending December 31, 2031. Annual increases are equal to the lesser of (i) 5 percent of the number of shares of Class A Common Stock issued and outstanding on December 31 of the immediately preceding fiscal year and (ii) an amount

determined by the Board of Directors. As of the effective date of the 2021 SI Plan, no further stock awards have been or will be granted under the EI Plan or STI Plan.

As of March 31, 2022, the Company had 45,226,078 shares of Class A Common Stock available for future issuance under its 2021 SI Plan.

A summary of the Company’s stock option activity under the SI Plan is as follows:


	Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value
Outstanding as of December 31, 2021	—
Granted	4,347,492	5.15
Exercised	—
Cancelled/forfeited	—
Outstanding as of March 31, 2022	4,347,492	$	5.15	9.79	$	498

The weighted-average assumptions used in the Black-Scholes option pricing model for awards granted during the three months ended March 31, 2022 are as follows:



Risk-free interest rate:	1.61	%
Expected term (in years):	7.01
Expected volatility:	43.50	%
Dividend yield:	0.00	%

As of March 31, 2022, the total remaining stock-based compensation expense for unvested stock options was $6,287, which is expected to be recognized over a weighted average period of 2.6 years.

EI Plan

On February 1, 2018, the Board of Directors adopted the Equity Incentive Plan (“EI Plan”), under which the Board of Directors authorized the grant of up to 42,390,000 incentive and nonqualified stock options, restricted stock, unrestricted stock, restricted stock units, and other stock-based awards for Legacy FF’s Class A Ordinary Stock to employees, directors, and non-employees.

A summary of the Company’s stock option activity under the EI Plan is as follows:


	Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value
Outstanding as of December 31, 2021	31,962,921	$	2.81	7.77	$	86,075
Granted	—
Exercised	(268,702)	2.50			729
Cancelled/forfeited	(1,049,835)	3.40
Outstanding as of March 31, 2022	30,644,384	$	2.79	7.34	$	73,051

As of March 31, 2022, the total remaining stock-based compensation expense for unvested stock options was $10,813, which is expected to be recognized over a weighted average period of 2.83 years.

STI Plan

The Special Talent Incentive Plan (“STI Plan”) allows the Board of Directors to grant up to 14,130,000 incentive and nonqualified stock options, restricted shares, unrestricted shares, restricted share units, and other stock-based awards for Legacy FF’s Class A Ordinary Stock to employees, directors, and non-employees.

The STI Plan does not specify a limit on the number of stock options that can be issued under the plan. Per the terms of the STI Plan, the Company must reserve and keep available a sufficient number of shares to satisfy the requirements of the STI Plan.

A summary of the Company’s stock option activity under the STI Plan is as follows:


	Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value
Outstanding as of December 31, 2021	9,526,727	$	5.55	8.0	$	13,905
Granted	—
Exercised	(492,973)	2.41			1,037
Cancelled/forfeited	(243,815)	8.02
Outstanding as of March 31, 2022	8,789,939	$	5.74	8.4	$	10,759

As of March 31, 2022, the total remaining stock-based compensation expense for unvested stock options was $6,669, which is expected to be recognized over a weighted average period of approximately 3.76 years.

The following table presents stock-based compensation expense included in each respective expense category in the unaudited Condensed Consolidated Statements of Operations and Other Comprehensive Loss:


	Three Months Ended March 31,
	2022		2021
Research and development	$	1,622	$	591
Sales and marketing	374		199
General and administrative	1,350		1,730
	$	3,347	$	2,520